 |
PDBsum entry 4jjs
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4jjs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of hcv ns5b polymerase in complex with compound 2
|
|
Structure:
|
 |
Genome polyprotein. Chain: a, b. Fragment: RNA-directed RNA polymerase, unp residues 2420-2989. Synonym: core protein p21, capsid protein c, p21, core protein p19, envelope glycoprotein e1, gp32, gp35, envelope glycoprotein e2, ns1, gp68, gp70, p7, protease ns2-3, p23, serine protease ns3, hepacivirin, ns3p, p70, non-structural protein 4a, ns4a, p8, non- structural protein 4b, ns4b, p27, non-structural protein 5a, ns5a, p56, RNA-directed RNA polymerase, ns5b, p68.
|
|
Source:
|
 |
Hepatitis c virus. Hcv. Organism_taxid: 420174. Strain: ibj4. Gene: ns5b. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.20Å
|
R-factor:
|
0.236
|
R-free:
|
0.272
|
|
|
Authors:
|
 |
R.Coulombe
|
|
Key ref:
|
 |
P.L.Beaulieu
et al.
(2013).
Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: discovery of a quinazolinone chemotype.
Bioorg Med Chem Lett,
23,
4132-4140.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Mar-13
|
Release date:
|
12-Jun-13
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O92972
(POLG_HCVJ4) -
Genome polyprotein from Hepatitis C virus genotype 1b (strain HC-J4)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
3010 a.a.
559 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.2.7.7.48
- RNA-directed Rna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
RNA(n)
|
+
|
ribonucleoside 5'-triphosphate
|
=
|
RNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.3.4.21.98
- hepacivirin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1'.
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.3.4.22.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
E.C.3.6.1.15
- nucleoside-triphosphate phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
|
 |
 |
 |
 |
 |
ribonucleoside 5'-triphosphate
|
+
|
H2O
|
=
|
ribonucleoside 5'-diphosphate
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
E.C.3.6.4.13
- Rna helicase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + H2O = ADP + phosphate + H+
|
 |
 |
 |
 |
 |
ATP
|
+
|
H2O
|
=
|
ADP
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
23:4132-4140
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: discovery of a quinazolinone chemotype.
|
|
P.L.Beaulieu,
R.Coulombe,
J.Duan,
G.Fazal,
C.Godbout,
O.Hucke,
A.Jakalian,
M.A.Joly,
O.Lepage,
M.Llinàs-Brunet,
J.Naud,
M.Poirier,
N.Rioux,
B.Thavonekham,
G.Kukolj,
T.A.Stammers.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We describe the structure-based design of a novel lead chemotype that binds to
thumb pocket 2 of HCV NS5B polymerase and inhibits cell-based gt1 subgenomic
reporter replicons at sub-micromolar concentrations (EC50<200nM). This new
class of potent thumb pocket 2 inhibitors features a 1H-quinazolin-4-one
scaffold derived from hybridization of a previously reported, low affinity
thiazolone chemotype with our recently described anthranilic acid series. Guided
by X-ray structural information, a key NS5B-ligand interaction involving the
carboxylate group of anthranilic acid based inhibitors was replaced by a neutral
two-point hydrogen bonding interaction between the quinazolinone scaffold and
the protein backbone. The in vitro ADME and in vivo rat PK profile of
representative analogs are also presented and provide areas for future
optimization of this new class of HCV polymerase inhibitors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |